Clinical Trials Directory

Trials / Completed

CompletedNCT00353704

Analgetic and Anxiolytic Effect of Preoperative Pregabalin

Analgetic and Anxiolytic Effect of Preoperative Pregabalin in Patients Undergoing Surgery of the Vertebral Columna

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Asker & Baerum Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether the use of oral pregabalin 150 mg as premedication reduces the amount and degree of postoperative pain. Furthermore the purpose of this study is to determine whether the use of oral pregabalin 150 mg as premedication reduces anxiety prior to anaesthesia in these patients.

Detailed description

The mechanism of development of postoperative pain is complex. Central and peripheral sensitization are playing an important role and this can lead to postoperative hypersensitization. Several studies have shown, that gabapentin can be effective to reduce sensitization and postoperative pain. Pregabalin (S-aminomethyl-5-methylhexaninacid) is a further development of gabapentin. Pregabalin has a fewer side-effects compared with gabapentin. The purpose of this study is to compare the analgetic and anxiolytic effect of pregabalin and placebo used as premedication. The hypothesis is that a single-dose pregabalin (150 mg postoperatively (p.o.)) gives significant better anxiolysis and analgesia than placebo. The study is including patients undergoing surgery of the vertebral columna.

Conditions

Interventions

TypeNameDescription
DRUGpregabalincapsule 150 mg x 1 per orally one hour before surgery
DRUGPlaceboOne capsule of saccharose (placebo) was administered about one hour before surgery
DRUGmorphineAll patients were equipped with a PCA (patient controlled analgesia) for 24 hours after surgery. The sum of morphine used was registered (milligram).

Timeline

Start date
2005-11-01
Primary completion
2009-05-01
Completion
2010-06-01
First posted
2006-07-19
Last updated
2011-07-20
Results posted
2011-07-20

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00353704. Inclusion in this directory is not an endorsement.